miR-26b suppressed cervical cancer cell proliferation and apoptosis by targeting ATF2 through MAPK1/ERK2 pathway

Minerva Endocrinol. 2019 Dec;44(4):405-407. doi: 10.23736/S0391-1977.19.03068-2. Epub 2019 Oct 11.

Authors

Yan Xiao¹, Li Wang¹, Liu Yang¹, Xiao Yu¹, Shuxia Cheng¹, Fei Ma¹, Huijun Cheng²

Affiliations

¹ Department of Gynecology, Cancer Hospital of Zhengzhou University (Henan Tumor Hospital), Zhengzhou, China.
² Department of Gynecology, Cancer Hospital of Zhengzhou University (Henan Tumor Hospital), Zhengzhou, China - chjf2580@163.com.

PMID: 31625711
DOI: 10.23736/S0391-1977.19.03068-2

No abstract available

Publication types

Letter

MeSH terms

Activating Transcription Factor 2 / biosynthesis
Activating Transcription Factor 2 / genetics*
Apoptosis / drug effects
Cell Line, Tumor
Cell Proliferation
Down-Regulation / drug effects
Female
Humans
MAP Kinase Signaling System / drug effects*
MicroRNAs / pharmacology*
Mitogen-Activated Protein Kinase 1 / genetics*
Uterine Cervical Neoplasms / drug therapy*
Uterine Cervical Neoplasms / pathology*

Substances

ATF2 protein, human
Activating Transcription Factor 2
MIRN26A microRNA, human
MicroRNAs
MAPK1 protein, human
Mitogen-Activated Protein Kinase 1